209 related articles for article (PubMed ID: 23992851)
41. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
[TBL] [Abstract][Full Text] [Related]
42. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.
Olarte L; Ampofo K; Stockmann C; Mason EO; Daly JA; Pavia AT; Byington CL
Pediatrics; 2013 Jul; 132(1):e17-24. PubMed ID: 23733800
[TBL] [Abstract][Full Text] [Related]
43. The future of pneumococcal disease prevention.
Rodgers GL; Klugman KP
Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
[TBL] [Abstract][Full Text] [Related]
44. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
[TBL] [Abstract][Full Text] [Related]
45. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.
Kaplan SL; Barson WJ; Lin PL; Stovall SH; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
Pediatrics; 2010 Mar; 125(3):429-36. PubMed ID: 20176669
[TBL] [Abstract][Full Text] [Related]
46. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
[TBL] [Abstract][Full Text] [Related]
47. Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece.
Grivea IN; Tsantouli AG; Michoula AN; Syrogiannopoulos GA
Vaccine; 2011 Nov; 29(48):8882-7. PubMed ID: 21963873
[TBL] [Abstract][Full Text] [Related]
48. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
[TBL] [Abstract][Full Text] [Related]
49. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.
Rosen JB; Thomas AR; Lexau CA; Reingold A; Hadler JL; Harrison LH; Bennett NM; Schaffner W; Farley MM; Beall BW; Moore MR;
Clin Infect Dis; 2011 Jul; 53(2):137-43. PubMed ID: 21690620
[TBL] [Abstract][Full Text] [Related]
50. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.
Guevara M; Barricarte A; Gil-Setas A; García-Irure JJ; Beristain X; Torroba L; Petit A; Polo Vigas ME; Aguinaga A; Castilla J
Clin Microbiol Infect; 2009 Nov; 15(11):1013-9. PubMed ID: 19673968
[TBL] [Abstract][Full Text] [Related]
51. Lower immunoglobulin G antibody responses to pneumococcal conjugate vaccination at the age of 2 years after previous nasopharyngeal carriage of Streptococcus pneumoniae.
Rodenburg GD; van Gils EJ; Veenhoven RH; Bogaert D; van den Dobbelsteen GP; Berbers GA; Sanders EA
J Pediatr; 2011 Dec; 159(6):965-70.e1. PubMed ID: 21813135
[TBL] [Abstract][Full Text] [Related]
52. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
[TBL] [Abstract][Full Text] [Related]
53. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department.
Sard B; Bailey MC; Vinci R
Pediatr Emerg Care; 2006 May; 22(5):295-300. PubMed ID: 16714955
[TBL] [Abstract][Full Text] [Related]
54. The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea.
Stamboulidis K; Chatzaki D; Poulakou G; Ioannidou S; Lebessi E; Katsarolis I; Sypsa V; Tsakanikos M; Kafetzis D; Tsolia MN
Pediatr Infect Dis J; 2011 Jul; 30(7):551-5. PubMed ID: 21297521
[TBL] [Abstract][Full Text] [Related]
55. Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland.
Clarke SC; Jefferies JM; Smith AJ; McMenamin J; Mitchell TJ; Edwards GF
J Clin Microbiol; 2006 Apr; 44(4):1224-8. PubMed ID: 16597842
[TBL] [Abstract][Full Text] [Related]
56. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
[TBL] [Abstract][Full Text] [Related]
57. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009.
Ho PL; Chiu SS; Ang I; Lau YL
Vaccine; 2011 Apr; 29(17):3270-5. PubMed ID: 21352937
[TBL] [Abstract][Full Text] [Related]
58. Pneumococcal disease manifestation in children before and after vaccination: what's new?
Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
[TBL] [Abstract][Full Text] [Related]
59. Outcomes of febrile children without localising signs after pneumococcal conjugate vaccine.
Waddle E; Jhaveri R
Arch Dis Child; 2009 Feb; 94(2):144-7. PubMed ID: 18539684
[TBL] [Abstract][Full Text] [Related]
60. Rapid decrease of 7-valent conjugate vaccine coverage for invasive pneumococcal diseases in pediatric patients in Japan.
Chiba N; Morozumi M; Shouji M; Wajima T; Iwata S; Sunakawa K; Ubukata K;
Microb Drug Resist; 2013 Aug; 19(4):308-15. PubMed ID: 23480525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
